Similarly, the MSI MANTIS score was higher in cancers with multiple MCM2 mutations (0.32; 0.30–0.74) than no MCM2 mutations (0.30; 0.29–0.33, p < 0.05) (Figure 5E). Here, MCM2 is linked to cancer.